Unibest
← Back to patent-cliff list

Epinephrine intranasal spray (ARS Pharmaceuticals)

Tier C — Watch / trade

Epinephrine intranasal spray (ARS Pharmaceuticals)

ARS Pharmaceuticals Inc
Originator
2024
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:β-adrenoceptors, α-adrenoceptors

Brand:Neffy, EUR neffy, EURneffy

Indications (approved):Allergic reaction

Regional status

US
Approved
2024-08-09
EU
Approved
2024-06-28
China
Approved
2025-12-22
Japan
Approved
2025-09-19

Synthetic routes & intermediates7 routes

Originator routes × 0Optimised (non-patent) × 7Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OptimisedRoute 1Steps 2 · Total yield /
(I)275500-1-a54917-85-0(II)275500-1-a107-97-1(III)275500-1-a1510840-02-4API · Epinephrine intranasal spray (ARS Pharmaceuticals)
CodeCAS No.Intermediate
(I)275500-1-a54917-85-04-Formyl-1,2-phenylene dibenzoate
(II)275500-1-a107-97-1(Methylamino)ethanoic acid
(III)275500-1-a1510840-02-44-(3-Methyl-1,3-oxazolidin-5-yl)-1,2-phenylene dibenzoate
OptimisedRoute 2Steps 3 · Total yield /
(I)275500-2-a120-80-9(II)275500-2-a79-04-9(III)275500-2-a99-40-1(IV)275500-2-a103-67-3(V)275500-2-a36467-25-1(VI)275500-2-a329-65-7(VII)275500-2-a150-05-0(VIII)275500-2-a5985-28-4(IX)275500-2-a66632-18-6(X)275500-2-a87697-27-6API · Epinephrine intranasal spray (ARS Pharmaceuticals)
CodeCAS No.Intermediate
(I)275500-2-a120-80-91,2-Dihydroxybenzene
(II)275500-2-a79-04-9Available2-Chloranylethanoyl chloride
(III)275500-2-a99-40-12-Chloro-1-(3,4-dihydroxyphenyl)ethanone
(IV)275500-2-a103-67-3N-Benzyl-N-methylamine
(V)275500-2-a36467-25-12-[Benzyl(methyl)amino]-1-(3,4-dihydroxyphenyl)ethan-1-one
(VI)275500-2-a329-65-7(±)-2-(3,4-Dihydroxyphenyl)-2-hydroxy-N-methylethylamine
(VII)275500-2-a150-05-0(+)-4-[1(S)-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(VIII)275500-2-a5985-28-44-[1-Hydroxy-2-(methylamino)ethyl]phenol hydrogen chloride
(IX)275500-2-a66632-18-6N-Boc-synephrine
(X)275500-2-a87697-27-6N-Boc-racepinephrine
OptimisedRoute 3Steps 2 · Total yield /
(I)275500-3-a99-45-6(II)275500-3-a65279-36-9API · Epinephrine intranasal spray (ARS Pharmaceuticals)
CodeCAS No.Intermediate
(I)275500-3-a99-45-61-(3,4-Dihydroxyphenyl)-2-(methylamino)ethanone
(II)275500-3-a65279-36-92-Acetoxy-4-[2-(methylamino)acetyl]phenyl acetate
OptimisedRoute 4Steps 3 · Total yield /
(I)275500-4-a99-40-1(II)275500-4-a74-89-5(III)275500-4-a62-13-5(IV)275500-4-a329-65-7API · Epinephrine intranasal spray (ARS Pharmaceuticals)
CodeCAS No.Intermediate
(I)275500-4-a99-40-12-Chloro-1-(3,4-dihydroxyphenyl)ethanone
(II)275500-4-a74-89-5Aminomethane
(III)275500-4-a62-13-51-(3,4-Dihydroxyphenyl)-2-(methylamino)ethan-1-one hydrochloride
(IV)275500-4-a329-65-7(±)-2-(3,4-Dihydroxyphenyl)-2-hydroxy-N-methylethylamine
OptimisedRoute 5Steps 5 · Total yield /
(I)275500-5-a120-80-9(II)275500-5-a53270-13-6(III)275500-5-a2243120-32-1(IV)275500-5-a79-04-9(V)275500-5-a2243120-33-2(VI)275500-5-a74-89-5(VII)275500-5-a2243120-34-3(VIII)275500-5-a2243120-35-4API · Epinephrine intranasal spray (ARS Pharmaceuticals)
CodeCAS No.Intermediate
(I)275500-5-a120-80-91,2-Dihydroxybenzene
(II)275500-5-a53270-13-62-O-Acetyl-3,4,6-tri-O-benzyl-alpha-D-glucopyranosyl bromide
(III)275500-5-a2243120-32-12-Hydroxyphenyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-glucopyranoside
(IV)275500-5-a79-04-9Available2-Chloranylethanoyl chloride
(V)275500-5-a2243120-33-24-(Chloroacetyl)-2-hydroxyphenyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-glucopyranoside
(VI)275500-5-a74-89-5Aminomethane
(VII)275500-5-a2243120-34-32-Hydroxy-4-[(methylamino)acetyl]phenyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-glucopyranoside
(VIII)275500-5-a2243120-35-42-Hydroxy-4-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-glucopyranoside
OptimisedRoute 6Steps 4 · Total yield /
(I)275500-6-a120-80-9(II)275500-6-a79-04-9(III)275500-6-a99-40-1(IV)275500-6-a955396-11-9(V)275500-6-a51-41-2(VI)275500-6-a74-89-5API · Epinephrine intranasal spray (ARS Pharmaceuticals)
CodeCAS No.Intermediate
(I)275500-6-a120-80-91,2-Dihydroxybenzene
(II)275500-6-a79-04-9Available2-Chloranylethanoyl chloride
(III)275500-6-a99-40-12-Chloro-1-(3,4-dihydroxyphenyl)ethanone
(IV)275500-6-a955396-11-94-[(1R)-2-Chloro-1-hydroxyethyl]benzene-1,2-diol
(V)275500-6-a51-41-2(-)-4-[2-Amino-1(R)-hydroxyethyl]-1,2-benzenediol
(VI)275500-6-a74-89-5Aminomethane
OptimisedRoute 7Steps 1 · Total yield /
(I)275500-7-a99-40-1(II)275500-7-a1385789-37-6API · Epinephrine intranasal spray (ARS Pharmaceuticals)
CodeCAS No.Intermediate
(I)275500-7-a99-40-12-Chloro-1-(3,4-dihydroxyphenyl)ethanone
(II)275500-7-a1385789-37-64-[(1S)-2-Chloro-1-hydroxyethyl]benzene-1,2-diol

Frequently asked questions

What are the approved indications of Epinephrine intranasal spray (ARS Pharmaceuticals)?

Approved indications include: Allergic reaction.

When does the Epinephrine intranasal spray (ARS Pharmaceuticals) patent expire?

No public expiry year is available for Epinephrine intranasal spray (ARS Pharmaceuticals) yet; this page updates once verified.

How many synthesis routes are recorded for Epinephrine intranasal spray (ARS Pharmaceuticals)?

7 synthesis routes are recorded; the shortest is 1 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Epinephrine intranasal spray (ARS Pharmaceuticals) intermediates?

1 intermediate CAS of Epinephrine intranasal spray (ARS Pharmaceuticals) are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Epinephrine intranasal spray (ARS Pharmaceuticals) intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29